Management of Incidental Findings
Lisa Parker has published on the management of incidental findings in neuroscience research (Accountability in Research, 2008) and genetic research (Journal of Law, Medicine & Ethics, 2008; Genetics in Medicine, 2012), and analyzed the appropriate role for preferences in managing IFs and returning individual results (Minnesota Journal of Law, Science & Technology, 2012).
Research on Mild Cognitive Impairment and Alzheimer Disease
Jennifer Lingler, Jennifer Seaman, and Lisa Parker, with colleagues, have published a series of papers on issues in conducting research involving individuals with MCI or AD, including: “Caregivers as Subjects of Clinical Drug Trials” in IRB: Ethics & Human Research (2006), “Psychometric Properties of a Decisional Capacity Screening Tool for Individuals Contemplating Participation in Alzheimer’s Disease Research” in Journal of Alzheimer’s Disease (2015), and “Research Use of Ecological Momentary Assessment for Adverse Event Monitoring Following Amyloid-β Results Disclosure” in Journal of Alzheimer’s Disease (2010).
Howard Degenholtz and Lisa Parker published an analysis of Treatment as Usual (TAU) as a control arm in intervention studies, in the International Journal of Geriatric Psychiatry (2001) and Ethics and Behavior (2002).